ENT features
Robotic surgery for squamous cell cancer: the new frontiers
Although the da Vinci platform was FDA approved for early-stage oropharyngeal cancers, the indications have expanded. In this article, John Hardman explains how surgeons, with greater understanding of the strengths and limitations of robotic surgery, have systematically set out to...
Head and neck robotic surgery – considerations for the surgical trainee
In 2021, training in head and neck cancer surgery would be incomplete without some robotic resections under the belt. Henry Zhang explains how he did it and outlines the options available. With a wide range of applications in both benign...
Machine learning and the future of otolaryngology
If you are over 30 years of age, you have witnessed a technology revolution that has grossly affected how we live: computers have come from being an oddity to an everyday feature in our households and places of work; the...
Head and neck cancer multidisciplinary team
Why do we have MDTs? Do they make a difference to outcomes? Jon Bernstein explores the whys and wherefores of the head and neck cancer MDT, and wonders where things might go from here… Head and neck (upper aerodigestive tract)...
The future of head and neck cancer surgery
Neil Sharma paints an exciting picture of the future of head and neck surgery with nanobots and robot augmented humans – science fiction or reality? Time will tell. ‘May you live in interesting times’ reads the old Chinese curse. The...
BACO International 2018: Key Speakers
Prof Aldo C Stamm, MD, MSc, PhD Anatomy of the paranasal sinuses and skull base, and breaking the paradigms in severe spontaneous epistaxis It is a true honour to participate as an invited faculty member at the upcoming BACO International...
Have we reached our limits in endoscopic skull base surgery?
As being an anterior skull base surgeon becomes the aspiration of many ENT trainees, Professor Nicolai gives his personal insights into the future for this exciting subspeciality. Having been directly involved in the evolution of transnasal endscopic surgery (TES) since...
Thyroid cancer – the last decade
Professor Ashok Shaha describes the evolution in the treatment of thyroid cancer that he has witnessed over the last decade and the invaluable progress made by himself and others, from their contributions to staging systems and guidelines. Nuances and paradigm...
Intraoperative nerve monitoring: 2017
Having written the definitive text on laryngeal nerves, Gregory Randolph and Dipti Kamani describe the benefits of intraoperative neural monitoring and, importantly, how to proceed if the nerve is pathologically involved or there is loss of signal. Over the years,...
Lessons learned from running a national thyroid surgery registry
The UK Registry of Endocrine and Thyroid Surgery is now yielding the rewards of meticulous data collection and years of hard work. David Scott-Coombes discusses the advantages and the unintended consequences of their success. The British Association of Endocrine and...
Surgical challenges in advanced or recurrent thyroid malignancy
The management of thyroid malignancy and extent of surgery is controversial, especially considering the limitations of preoperative diagnosis. Neil Tolley provides guidance and reminds us of our responsibility not to over-treat. In the UK, 16% of thyroidectomies are performed for...
Systemic agents in thyroid cancer
For those patients who have disseminated or unresectable thyroid cancer, Dr Arabella Hunt and Dr Kate Newbold review systemic treatments, their differences, toxicities and outcomes. Thyroid cancer is the most common endocrine malignancy. It is subdivided into differentiated (papillary, follicular...
